Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00178607 · ClinicalTrials.gov registry record
Covalent Tolerance Induction to Factor VIII-Prediction of Inhibitors in Hemophilia
A clinical trial, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- 99
- Enrollment target
NCT00178607: Completed study, sponsored by The University of Texas Health Science Center, Houston.
NCT00178607 is a clinical trial that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 99 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00178607 has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- 99 participants
- Enrollment target
Study Summary
To correlate the Human Leukocyte Antigen type and genetic defect with hemophilia A.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2002-08 |
| Est. Completion | 2015-10 |
What the finished NCT00178607 record still lists
NCT00178607 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 99 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00178607 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00178607 about?
NCT00178607 is a clinical study titled "Covalent Tolerance Induction to Factor VIII-Prediction of Inhibitors in Hemophilia". To correlate the Human Leukocyte Antigen type and genetic defect with hemophilia A.
What is the current status of trial NCT00178607?
This trial is currently completed. The enrollment target is 99 participants. The study started on 2002-08. Estimated completion is 2015-10.
Who is sponsoring clinical trial NCT00178607?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03965234 · 99 participants · Phase 1
Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases
- NCT04022616 · 99 participants
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
- NCT04042844 · 99 participants · Phase 2
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
- NCT04143724 · 99 participants · Phase 2
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia